ATE365736T1 - Etherderivate, deren herstellung und deren verwendung als pharmazeutische mittel - Google Patents

Etherderivate, deren herstellung und deren verwendung als pharmazeutische mittel

Info

Publication number
ATE365736T1
ATE365736T1 AT05716141T AT05716141T ATE365736T1 AT E365736 T1 ATE365736 T1 AT E365736T1 AT 05716141 T AT05716141 T AT 05716141T AT 05716141 T AT05716141 T AT 05716141T AT E365736 T1 ATE365736 T1 AT E365736T1
Authority
AT
Austria
Prior art keywords
production
pharmaceutical products
ether derivatives
derivatives
ether
Prior art date
Application number
AT05716141T
Other languages
English (en)
Inventor
Birgit Bossenmaier
Walter-Gunar Friebe
Thomas Friess
Ulrike Reiff
Edgar Voss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE365736T1 publication Critical patent/ATE365736T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
AT05716141T 2004-03-18 2005-03-17 Etherderivate, deren herstellung und deren verwendung als pharmazeutische mittel ATE365736T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04006509 2004-03-18

Publications (1)

Publication Number Publication Date
ATE365736T1 true ATE365736T1 (de) 2007-07-15

Family

ID=34924516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05716141T ATE365736T1 (de) 2004-03-18 2005-03-17 Etherderivate, deren herstellung und deren verwendung als pharmazeutische mittel

Country Status (15)

Country Link
US (1) US7432291B2 (de)
EP (1) EP1727815B1 (de)
JP (1) JP2007529460A (de)
KR (1) KR100836552B1 (de)
CN (1) CN1930154A (de)
AR (1) AR048434A1 (de)
AT (1) ATE365736T1 (de)
AU (1) AU2005223335A1 (de)
BR (1) BRPI0508925A (de)
CA (1) CA2559553A1 (de)
DE (1) DE602005001505T2 (de)
ES (1) ES2289699T3 (de)
RU (1) RU2006136523A (de)
TW (1) TW200533346A (de)
WO (1) WO2005090338A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5919291B2 (ja) * 2010-11-09 2016-05-18 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｇａｂａ受容体リガンドとしてのトリアゾール誘導体
US8742097B2 (en) * 2010-11-09 2014-06-03 Hoffmann-La Roche Inc. Triazole compounds I
CA2995617A1 (en) * 2017-11-03 2019-05-03 Universite De Montreal Heterocyclic mitochondrial activity inhibitors and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0912562A1 (de) 1996-07-19 1999-05-06 Takeda Chemical Industries, Ltd. Heterocyclische verbindungen, ihre herstellung und verwendung
PE20011178A1 (es) 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion
US6984653B2 (en) 2001-10-05 2006-01-10 Takeda Pharmaceutical Company Limited Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
JP2003277379A (ja) * 2002-01-17 2003-10-02 Takeda Chem Ind Ltd 含窒素複素環化合物、その製造法および用途
AU2003203170A1 (en) * 2002-01-17 2003-07-30 Takeda Chemical Industries, Ltd. Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
TW200531688A (en) * 2004-03-05 2005-10-01 Hoffmann La Roche Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
US7163953B2 (en) * 2004-05-25 2007-01-16 Hoffmann-La Roche Inc. Benzylether derivatives

Also Published As

Publication number Publication date
EP1727815A1 (de) 2006-12-06
DE602005001505T2 (de) 2008-02-28
CN1930154A (zh) 2007-03-14
TW200533346A (en) 2005-10-16
DE602005001505D1 (de) 2007-08-09
US7432291B2 (en) 2008-10-07
AR048434A1 (es) 2006-04-26
WO2005090338A1 (en) 2005-09-29
AU2005223335A1 (en) 2005-09-29
EP1727815B1 (de) 2007-06-27
ES2289699T3 (es) 2008-02-01
JP2007529460A (ja) 2007-10-25
RU2006136523A (ru) 2008-04-27
KR100836552B1 (ko) 2008-06-10
BRPI0508925A (pt) 2007-08-14
US20050209290A1 (en) 2005-09-22
CA2559553A1 (en) 2005-09-29
KR20060124757A (ko) 2006-12-05

Similar Documents

Publication Publication Date Title
ATE420072T1 (de) Neue alkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel
DE50312295D1 (de) 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel
DE602005006815D1 (de) 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung
ATE372998T1 (de) 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
ATE496919T1 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE498618T1 (de) Neue zyklische harnstoffderivate, deren herstellung und pharmazeutische verwendung damit als kinase-inhibitoren
ATE353900T1 (de) Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
ATE524178T1 (de) Acylierte, heteroaryl-kondensierte cycloalkenylamine und deren verwendung als arzneimittel
ATE489382T1 (de) Benzoxazinonderivate, deren herstellung und verwendung als arzneimittel
DE502005002105D1 (de) 4-benzimidazol-2-yl-pyridazin-3-on-derivative, ihre herstellung und verwendung in arzneimitteln
ATE538125T1 (de) Neue 2-azaindol-derivate, deren herstellung und pharmazeutische verwendung als kinase-inhibitoren
ATE542806T1 (de) Diarylmethylpiperazinderivate, deren herstellung und deren verwendung
ATE417846T1 (de) Aminotropanderivate, deren herstellung und deren therapeutische verwendung
ATE419244T1 (de) Neue cycloalkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel
DE602006005246D1 (de) Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung
ATE409190T1 (de) Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel
ATE555097T1 (de) 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente
DE602004030564D1 (de) 2-substituierte phenyl-5,7-dialkyl-3,7-dihydropyrrolä2,3-dü pyrimidin-4-onderivate, deren herstellung und pharmazeutische verwendung
DE602005012287D1 (de) Biotinylierte hexadecasaccharide, pharmazeutische zusammensetzungen daraus und deren verwendung
DE602004015600D1 (de) Neue imidazolderivative, deren herstellung und deren verwendung als medikament
ATE487706T1 (de) Cyclische n-ä1,3,4ü-thiadiazol-2-yl- benzsulfonamide, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE365736T1 (de) Etherderivate, deren herstellung und deren verwendung als pharmazeutische mittel
DE602004022169D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
DE602004028160D1 (de) (4-phenylpiperazin-1-yl)acylpiperidinderivate, deren herstellung und deren verwendung in therapeutka
DE602006008971D1 (de) N-ä(4,5-diphenylpyrimidin-2-yl)methylüaminderivate, deren herstellung und deren therapeutische verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties